Welcome to EURETINA’s fourth Educational Debate which took place on Monday 13th of December, 2021.
This 60-minute session comprised a double debate. First, we heard from Jean Francois Korobelnik (France) and Ian Pearce (UK) on the risk/benefit of the port delivery system in regards to its routine use in Neovascular AMD.
In debate 2, Baruch Kuppermann (USA) and Francesco Bandello (Italy) discussed the notion ‘In retinal vein occlusion all AntiVEGF agents act the same’.
Part 1: The risk/benefit of the port delivery system warrants its routine use in Neovascular AMD.
Part 2: In retinal vein occlusion all AntiVEGF agents act the same.
This event was moderated by Anat Loewenstein (Israel) and Sebastian Wolf (Switzerland), with Marta Figueroa (Spain) and Usha Chakravarthy (UK) on the discussion panel.
Schedule
- 00:00 – 00:02 – Welcome and Introduction Anat Loewenstein
- 00:02 – 00:02 – First debate – The risk/ benefit of port delivery system warrants its routine use in neovascular AMD
- 00:02 – 00:10 – In favour of the motion Jean-Francois Korobelnik
- 00:10 – 00:18 – Against the motion Ian Pearce
- 00:18 – 00:28 – Discussion
- 00:28 – 00:30 – Concluding first debate, introducing the Second debate Anat Loewenstein, Sebastian Wolf
- 00:30 – 00:30 – Second debate – In retinal vein occlusion, all anti VEGF agents act the same
- 00:30 – 00:38 – In favour of the motion Baruch Kuppermann
- 00:38 – 00:46 – Against the motion Francesco Bandello
- 00:46 – 00:56 – Discussion
- 00:56 – 01:00 – Closing address Anat Loewenstein / Sebastian Wolf
If you are an EURETINA Member, you can go to our Forum to continue the debate.
Please enjoy this webinar playback, available to all members and non-members, free of charge. This webinar forms part of the EURETINA year-long digital events programme. See the current programme here. Programme events are generally available for anyone to sign up to and will be available for public viewing for a 2-week period following the live event. After this period, only EURETINA Members will be able to access the playback archive. Learn more about membership here.
